CYP2D6 POLYMORPHISMS AND ADVERSE EVENTS TO RISPERIDONE IN CHILDREN AND ADOLESCENTS.

被引：0
|
作者：
Neely, K. M. [1 ]
Oshikoya, K. A. [1 ]
Carroll, R. [1 ]
Aka, I. [1 ]
Maxwell-Horn, A. [1 ]
Roden, D. M. [1 ]
Van Driest, S. L. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PGRN-027
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [1] CYP2D6 POLYMORPHISMS AND ADVERSE EVENTS TO RISPERIDONE IN CHILDREN AND ADOLESCENTS.
    Neely, K. M.
    Oshikoya, K. A.
    Carroll, R.
    Aka, I.
    Maxwell-Horn, A.
    Roden, D. M.
    Van Driest, S. L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S107 - S108
  • [2] CYP2D6 genotype and adverse events to risperidone in children and adolescents
    Kazeem A. Oshikoya
    Katelyn M. Neely
    Robert J. Carroll
    Ida T. Aka
    Angela C. Maxwell-Horn
    Dan M. Roden
    Sara L. Van Driest
    [J]. Pediatric Research, 2019, 85 : 602 - 606
  • [3] CYP2D6 genotype and adverse events to risperidone in children and adolescents
    Oshikoya, Kazeem A.
    Neely, Katelyn M.
    Carroll, Robert J.
    Aka, Ida T.
    Maxwell-Horn, Angela C.
    Roden, Dan M.
    Van Driest, Sara L.
    [J]. PEDIATRIC RESEARCH, 2019, 85 (05) : 602 - 606
  • [4] CYP2D6 polymorphisms and their influence on risperidone treatment
    Puangpetch, Apichaya
    Vanwong, Natchaya
    Nuntamool, Nopphadol
    Hongkaew, Yaowaluck
    Chamnanphon, Monpat
    Sukasem, Chonlaphat
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2016, 9 : 131 - 147
  • [5] A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents
    Thomas Dodsworth
    David D. Kim
    Ric M. Procyshyn
    Colin J. Ross
    William G. Honer
    Alasdair M. Barr
    [J]. Child and Adolescent Psychiatry and Mental Health, 12
  • [6] Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents
    Kanu, Amarachi A.
    Johnston, Michelle M.
    Poweleit, Ethan A.
    Vaughn, Samuel E.
    Strawn, Jeffrey R.
    Ramsey, Laura B.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024, 34 (01) : 34 - 41
  • [7] A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents
    Dodsworth, Thomas
    Kim, David D.
    Procyshyn, Ric M.
    Ross, Colin J.
    Honer, William G.
    Barr, Alasdair M.
    [J]. CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH, 2018, 12
  • [8] Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort
    Dodgen, Tyren M.
    Eloff, Arinda
    Mataboge, Connie
    Roos, Louw
    van Staden, Werdie
    Pepper, Michael S.
    [J]. APPLIED AND TRANSLATIONAL GENOMICS, 2015, 5 : 40 - 46
  • [9] Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions
    LLerena, Adrian
    Dorado, Pedro
    Penas-LLedo, Eva M.
    [J]. PHARMACOGENOMICS, 2011, 12 (03) : 311 - 311
  • [10] Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
    Jinjun Lu
    Ye Yang
    Jian Lu
    Zuqing Wang
    Yiping He
    Yeliang Yan
    Kai Fu
    Wenjuan Jiang
    Yunqing Xu
    Renrong Wu
    Wenqing Liu
    Jingping Zhao
    [J]. BMC Psychiatry, 21
12345